Stryker announces leadership succession
Portage, Michigan, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, today announced that as part of a planned succession process, Kevin Lobo will transition to the role of Executive Chair of the Board of Directors, effective January 1, 2027. Spencer Stiles, currently President and Chief Operating Officer of Stryker, will succeed Lobo as Chief Executive Officer and will also be appointed as a member of the company’s Board at that time.
Covered in this story
What has happened since
- Stryker Corporation is up 9.2% since this was published, 14 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Stryker Corporation
- Truist Securities: $278 → $310 by Oct 2027 · Hold via Investing.com
- Needham: $278 → $418 by Oct 2027 · Buy via Investing.com
- Stifel: $275 → $330 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $SYK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Stryker Corporation →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.